Grazoprevir and Elbasvir in Patients with Genotype 1 Hepatitis C Virus Infection: A Comprehensive Efficacy and Safety Analysis
Background. It is urgent for patients with hepatitis C virus (HCV) infection to find a safe, effective, and interferon-free regimen to optimize therapy. A comprehensive analysis was performed to evaluate the efficacy and safety of the grazoprevir combined with elbasvir, with or without ribavirin (RB...
Saved in:
Main Authors: | Yinan Yao, Ming Yue, Jie Wang, Hongbo Chen, Mei Liu, Feng Zang, Jun Li, Yun Zhang, Peng Huang, Rongbin Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2017/8186275 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection
by: Yong-yu Mei, et al.
Published: (2020-01-01) -
Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C
by: Alaa Awad Taha, et al.
Published: (2010-01-01) -
Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary Study
by: Miguel Moncayo, et al.
Published: (2024-01-01) -
Comment on “Emergence of Hepatitis B Virus Genotype F in Aligarh Region of
North India”
by: Sibnarayan Datta
Published: (2014-01-01) -
Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of Liver
by: D. Ajith Roni, et al.
Published: (2013-01-01)